Penile Squamous Cell Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Molecular Characterization of Penile Cancers in Developing Countries (NCT06068998)	Latin American Cooperative Oncology Group	2021-12-17
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) (NCT03943602)	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano	2019-08-01
Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma (NCT03774901)	Centre Hospitalier Universitaire de Besancon	2019-03-12
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)	National Cancer Institute (NCI)	2017-01-30
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma (NCT02837042)	University of Alabama at Birmingham	2016-10-01
Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors (NCT02496208)	National Cancer Institute (NCI)	2015-07-22
Oral Rigosertib for Squamous Cell Carcinoma (NCT01807546)	Traws Pharma, Inc.	2013-03-01

Every clearance here is in the API, with alerts when new ones post.